Staff editor

MaaT Pharma secures €37.5M EIB financing to accelerate microbiome-driven breakthroughs in cancer care

With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.

Previewing the PPPP congress: Prof. Francavilla on gut microbiota and gluten-related disorders in children

Professor Ruggiero Francavilla, pediatric gastroenterologist at the Polyclinic of Bari (Italy), offers a preview of his upcoming talk at the 10th International Congress of Probiotics, Prebiotics, and Postbiotics in Pediatrics.

Fueling the future of microbiome science: inside the Global Grants for Gut Health

A unique partnership between Yakult and Nature Portfolio to build a global community of microbiome pioneers.

Looking ahead to the PPPP international congress: Berni Canani on microbiome-modulating strategies for allergy prevention

Professor Roberto Berni Canani, pediatrician at the University of Naples Federico II, previews the key topics he will present at the 10th International Congress of Probiotics, Prebiotics and Postbiotics in…

The gut-brain axis and the role of the intestinal barrier

The science behind gut-brain communication and the role of intestinal integrity.

PPPP international congress on pediatric microbiome: exploring new frontiers with probiotics and AI

Professor Flavia Indrio, President of the 10th International Congress on Probiotics, Prebiotics, and Postbiotics in Pediatrics, previews the key topics for the upcoming 2026 event in Lecce, April 16-18.

The gut microbiota impacts female infertility

Women with lower DI-GM scores showed a higher risk of infertility, highlighting the potential importance of gut microbiota diversity as a factor in female reproductive health.

Postbiotics and Biotic Vitamins: the new frontier of health

dsm-firmenich Italy successfully hosts its first exclusive event on biotics.

Microbiome milestone: MaaT Pharma and Clinigen team up to deliver innovative oncology therapy

Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.

Sacco System: advancing probiotic science from ingredients to innovation

Carlo Sala, Sales Director EMEA & LATAM - Microbiome BU at Sacco System, discusses the company innovative probiotic strains, tailored manufacturing services, and commitment to R&D.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top